Skip to content

Abstract

This review paper focuses on recent advancements in biosensing technologies for the detection of the cancer biomarker CD44. Five scientific studies conducted by researchers at Nazarbayev University are analyzed, covering optical fiber biosensors, electrochemical sensors, and green-synthesized nanomaterials. The main goal of this review is to highlight the importance of sensitive, label-free, and real-time detection methods in early cancer diagnosis. The studies demonstrate significant progress in achieving attomolar-level sensitivity, detecting whole cancer cells, and improving sensor performance using eco-friendly approaches. The paper also discusses the methodology, strengths, and potential limitations of each study. The findings suggest that these biosensors hold great promise for future clinical applications, especially in point-of-care testing and personalized medicine.